Logo Image
News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in MedicineShorts
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Emerging Pharma Leaders Awards|
Latest Executive Roundtables|
Asembia 2026|
Sales Effectiveness
Advertisement
|Articles|February 1, 2004

Pharmaceutical Executive

  • Pharmaceutical Executive-02-01-2004

February Table of Contents

February Table of Contents

Advertisement
External Link - article-85018.pdf

Articles in this issue

over 22 years ago

Article

Upping the Ante

over 22 years ago

Article

Knowing When to Pull the Plug On Your Experimental Drug
Advertisement

Related Content

Advertisement
Pharmaceutical Executive Daily

Pharmaceutical Executive Daily: Roche and Nurix Therapeutics Announce Global Collaboration

ByNicholas Jacobus
June 8th 2026
Stock.adobe.com business deal

Pharma M&A Roundup: Incyte to Acquire Vega Therapeutics, Galmed Pharmaceuticals to Acquire Colospan, Johnson & Johnson Acquires Firefly Bio

ByNicholas Jacobus
June 8th 2026
Stock.adobe.com deal

Roche Enters $2.3 Billion Global Collaboration with Nurix Therapeutics to Co-Develop and Co-Commercialize Bexobrutideg

ByNicholas Jacobus
June 8th 2026
Law, Jenkins, Chong

Beyond JAK Inhibitors: Biologics Signal a New Era in Alopecia Areata

ByJune See Chong, PhD,Holly Jenkins, PhD,Erin Law, MSc
June 8th 2026
Pharmaceutical Executive Daily

Pharmaceutical Executive Daily: Supreme Court Unanimously Rules in Favor of Hikma Pharmaceuticals in Skinny Label Case

ByNicholas Jacobus
June 5th 2026
Advertisement
Advertisement

Trending on PharmExec

1

Beyond JAK Inhibitors: Biologics Signal a New Era in Alopecia Areata

2

Pharma M&A Roundup: Incyte to Acquire Vega Therapeutics, Galmed Pharmaceuticals to Acquire Colospan, Johnson & Johnson Acquires Firefly Bio

3

Chai Discovery Enters License Agreement with Pfizer to Accelerate Drug Discovery with AI

4

Roche Enters $2.3 Billion Global Collaboration with Nurix Therapeutics to Co-Develop and Co-Commercialize Bexobrutideg

5

U.S. Supreme Court Unanimously Votes in Favor of Hikma in Case Against Amarin: Report

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us